Wells Pharma of Houston: multiple drugs
Wells Pharma recalls injectable solutions (phenylephrine, fentanyl, ketamine) over cGMP deviations.
Check your inventory for the affected products and lot numbers. Stop using and quarantine any recalled units. Contact Wells Pharma of Houston LLC for return and replacement instructions.
Why it was recalled
Wells Pharma of Houston LLC is recalling Phenylephrine Hydrochloride Injectable Solution, 40mg, 250mL bags, along with fentanyl citrate and ketamine hydrochloride injectable solutions, due to cGMP deviations. The recall affects multiple products distributed across the U.S.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
| Product | UPC | Recall # |
|---|---|---|
| fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per mL), well pharma of Houston, NDC 73702-203-65. | – | D-0506-2026 |
| Ketamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL, 5265 Kitty Drive, Houston, TX 77054, NDC 73702-302-31. | – | D-0507-2026 |
| fentaNYL Citrate injectable Solution in 0.9% Sodium Chloride, Narcotic, (2500 mcg/ 250 mL) (10 mcg per mL), 250 mL bag, wells pharma of Houston, NDC 73702-202-03. | 02182202030398 | D-0504-2026 |
| fentaNYL Citrate Injectable Solution, NARCOTIC, Cii, 1000 mcg/100 mL (10 mcg per mL), 100 mL bag, Wells Pharma in Houston, NDC 73702-202-02. | – | D-0503-2026 |
| Phenylephrine Hydrochloride Injectable Solution, 40mg, 250*mL Bag, wells pharma of Houston, NDC 73702-122-03 | – | D-0502-2026 |
| fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15. | – | D-0508-2026 |
| fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC 73702-204-25. | – | D-0505-2026 |
Where it was sold
Distributed nationwide.
Official source
Editorial summary by Recall Canary · last updated 2026-07-28 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification